Yunnan Baiyao Group Co., Ltd.

This early-stage study tests a new drug called INB301 in 146 adults with cancer who are experiencing cachexia—severe weight loss and muscle wasting. The goal is to see if the drug is safe and can help patients gain or maintain weight. The study is open-label, meaning everyone kno…